Related Experiment Video
Updated: Sep 8, 2025

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Beyond the 1%: Advocating for Comprehensive Data on Perinatal Substance Use in Canada
Jodie Bigalky1, April Mackey2, Oluwafemi Serrano3
1Assistant Professor College of Nursing University of Saskatchewan Saskatoon, SK.
None:
This paper addresses the critical issue of perinatal substance use (PSU) in Canada and highlights the urgent need for relevant and current prevalence data. PSU poses significant risks to perinatal and infant health, highlighting the need for targeted interventions that are grounded in comprehensive data and research. Comprehensive data collection must include disaggregated information by province and differentiate between various substances. Nurse leaders are uniquely positioned to advocate for these initiatives, enhance healthcare provider education and support ongoing research. A coordinated approach is essential for improving health outcomes for perinatal individuals and their families across Canada.
More Related Videos
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Teratogenicity
Drug Dependence
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Factors Affecting Drug Response: Overview
Analysis of Population Pharmacokinetic Data

